Web Analytics

3 Latest Announced Rounds

  • $3,500,000
    Seed

    1 Investors

    Technology, Information and Internet
    Dec 20th, 2024
  • $5,619,170
    Series B

    1 Investors

    Research Services
    Dec 20th, 2024
  • $8,000,000
    Unknown

    5 Investors

    Computer & Network Security
    Dec 20th, 2024
$671.88M Raised in 44 Funding Rounds in the past 7 Days - View All

Funding Round Profile

mPATH Health

start up
United States - Winston-Salem, NC
  • 06/03/2024
  • Unknown
  • $1,100,000

mPATH is a B2B software-as-a-service company that improves healthcare organizations’ bottom line with an automated platform that closes preventive care gaps. mPATH™ is a low-cost, cloud-based program that identifies individuals who are overdue for routine screening tests, provides personalized education, and connects patients with needed care. We believe that healthcare shouldn't be confined to a doctor's office. With its cloud-based design, mPATH™ reaches patients wherever they are and when they want.


Related People

David MillerFounder

David Miller United States - Winston-Salem, North Carolina

I am a board-certified clinical informaticist, primary care physician, and experienced health services investigator who is dedicated to transforming the way we deliver medical care. I have over 20 years of experience developing, studying, and implementing digital health interventions in primary care. My studies have included a systematic review of clinic-based computer-assisted instruction, randomized controlled trials of computer and web-based patient education programs/decision aids, and pilot studies with mobile devices in socioeconomically disadvantaged patient populations. Based on this experience, I developed an innovative software application called mPATH™ with over $6M in highly competitive funding from the NIH. mPATH™ is an automated program for health systems that identifies patients who are overdue for screening, educates them about their options, and connects them with needed care. In a randomized-controlled trial published in the peer-reviewed medical literature, mPATH™ doubled the proportion of patients who completed cancer screening. I founded Digital Health Navigation Solutions, a B2B software company, to further develop mPATH™ and make it broadly available to improve preventive care delivery.